QuantaBrain develops AI-driven software to analyze 1-minute resting state functional MRI (rs-fMRI) exams for objective diagnosis of neuropsychiatric disorders. This technology extracts individual brain activity signatures by analyzing oxygen consumption patterns across the brain, similar to urban traffic analysis. The resulting quantitative data supports personalized treatment planning by moving beyond conventional one-size-fits-all diagnostic approaches.
Funding
Funding not disclosed
SVFounders
Product
Problem
Traditional diagnostic methods for neurodevelopmental and neuropsychiatric disorders rely on subjective behavioral assessments, which can be inconsistent and may not capture the underlying biological basis of these conditions. This reliance on behavioral symptoms alone can lead to delayed or inaccurate diagnoses and limit the ability to personalize treatment plans effectively.
Solution
QuantaBrain offers AI-driven software that analyzes resting-state functional magnetic resonance imaging (rs-fMRI) data to identify atypical brain activity patterns associated with neurodevelopmental and neuropsychiatric disorders. By using a quick, one-minute rs-fMRI scan, the software provides objective, quantitative biomarkers that complement traditional diagnostic approaches. The AI algorithms analyze blood flow and oxygen consumption in the brain, leveraging techniques similar to urban traffic analysis to map brain activity. This approach aims to bridge the gap between neurology and psychiatry by providing a biological understanding of behavioral disorders, ultimately enabling clinicians to develop individualized treatment strategies based on a patient's unique brain activity signature. The technology is compatible with any MRI scanner and acquisition sequence, ensuring ease of integration into existing clinical workflows.
Target Audience
The primary target audience includes psychiatrists, radiologists, and other medical professionals involved in the diagnosis and treatment of neurodevelopmental and neuropsychiatric disorders.
Features
- AI-powered analysis of one-minute resting-state fMRI scans
- Identification of atypical brain activity patterns linked to neurodevelopmental and neuropsychiatric disorders
- Quantitative biomarkers to supplement traditional behavioral assessments
- Compatibility with any MRI scanner and MR acquisition sequence
- Non-invasive and sedation-free procedure, ensuring patient safety
- AI algorithms leveraging urban traffic analysis techniques to map brain activity